Report overview

The report states consolidated turnover of Taka 9,130,607,862 for 2013 and records total CSR expenditure of Taka 41,306,104. It also reports that Renata Oncology Limited commissioned a tablet facility toward the end of the year.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2013
Period: 1 January 2013 – 31 December 2013
Publication date: 29 April 2014
Language
Pages
File size

Standards & Assurance

Assurance

Statement included

ESG & Materiality

ESG data

No ESG data is available for this report.

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services